Published in Vaccine Weekly, April 11th, 2001
H. Sormunen and colleagues tested several regimens for immunization with inactivated poliovirus vaccine (IPV) and found that while all produced satisfactory antibody levels, some were more ideal than others.
"The age of the child at the first dose (one to four months) and the interval between the first and second doses (two to four months) influenced the initial responses in a serotype-dependent...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2001-04-11)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.